These observations suggest that lung cancer cells can be dedifferentiated by oxidative stress and that the transcription factor HOXA5 has a critical role and HOXA5 can be a reasonable molecular target of lung CSC/CIC-targeting therapy (Figure 6). The gene discussed is HOXA5; the disease is lung cancer.